Market Pulse
Airlines fly lower after Barcelona attack
Airline stocks took a nosedive on Friday morning as the horrific van attack in Barcelona the previous evening was felt likely to hit tourism to the region.
Commodities: Choppy day for gold as dollar steadies
Gold futures stabilized on Thursday as the US dollar remained subdued after Wednesday's minutes from the FOMC (Federal Open Market Committee) hinted at a delay in any rate hikes in the US.
FX round-up: ECB minutes reveal concern over euro strength, cable lower on the day
The latest round of ECB (European Central Bank) minutes out on Thursday revealed some concerns around recent euro strength, sending the single currency to its month-to-date lows versus the US dollar.
Undervalued Prudential could get huge upside from break-up - Credit Suisse
Prudential is already trading at a discount to the UK life insurance sector and, amid rumours of a potential break-up, Credit Suisse calculated there could be considerable upside from such a move.
Numis downgrades SIG, says recovery still in 'early days'
Analysts at Numis downgraded their recommendation on shares of SIG from 'hold' to 'reduce', saying the shares' valuation was up with events even while conceding the "good" recovery profile the company's shares offered.
Shanta Gold delivers termination notice to Helio Resource
Shanta Gold, has delivered notice to Helio Resource Corp of its termination of the arrangement agreement dated as of 19 June 2017.
PCG raises £1m in funding through new Riverfort agreement
PCG Entertainment announced it had successfully raised £1m in funding from a group of investors led by D-Beta One EQ and arranged by RiverFort Global Capital.
London open: Stocks slide following Wall St wobble, airlines hit by Barcelona fears
London stocks nosedived in early trade on Friday, with airlines leading the retreat after the terror attacks in Barcelona and following steep losses overnight on Wall Street amid renewed concerns about the Presidency.
Astrazeneca wins wider US approval for Lynparza ovarian cancer drug
AstraZeneca and Merck have been given approval by the US drug administrator to sell their olaparib ovarian cancer drug, branded Lynparza, in a new tablet form and to a wider range of cancer sufferers.
Friday newspaper round-up: Brexit deals, White House, productivity, Cuadrilla
EU migrants will be barred from claiming in-work benefits unless they have been employed for at least four years after Brexit under plans to revive a pledge by David Cameron. Ministers are understood to be examining plans to bar migrants who arrive in the UK after March 2019 from claiming in-work benefits unless they have worked in the UK and "contributed" for four years. - The Telegraph.
German factory prices dip in July
Factory prices in the Eurozone's largest economy slipped by slightly less than was anticipated last month.
London pre-open: Stocks to start lower on US politics, Barcelona attack
Stocks are set for a lower open following steep losses overnight on Wall Street that saw the Dow Industrials register its biggest drop in three months and the S&P 500 its largest decline in more than a month.
CMA approves Heineken's Punch purchase if 33 pubs are sold
The UK competition regulator has approved the sale of a swathe of Punch Taverns' pubs to Heineken as long as the Dutch brewer sells .